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Introduction
Escherichia coli is the major pathogen in many extraintestinal Gram-negative bacillus infections. Several virulence factors of E. coli are responsible for colonization and invasion of the host, and/or serve to avoid or disrupt host defense mechanisms. Both E. coli virulence characteristics and host factors contribute to the development of E. coli bacteremia in upper urinary tract infection (UTI). 1 Patients with diabetes mellitus have an increased risk for infections, including UTI, soft tissue infections, communityacquired pneumonia, necrotizing otitis externa, and bloodstream infections.
2,3 Impaired host defense, in both cell-mediated immunity and humoral immunity, increases the susceptibility to infection. Diabetes-associated functional and anatomical abnormalities of the host also contribute to it. Poor glycemic control increases the risk of community-acquired infections and acquiring asymptomatic bacteriuria (ABU). 4, 5 Diabetes with poor glycemic control and urinary tract obstruction are important host factors predisposing to emphysematous pyelonephritis. 6 In most E. coli extraintestinal infections, host immunocompetence is associated with a relatively high prevalence of papG II, afa and iha, and relatively low antimicrobial resistance to fluoroquinolones. 7 The role of bacterial characteristics and glycemic control in diabetic patients with E. coli infections related to urinary tract has not been well investigated. The aims of this study were to examine and compare the bacterial characteristics and glycemic control in diabetic patients with E. coli infections arising in the urinary tract.
Materials and methods

Subjects and bacterial strains
A total of 271 E. coli random isolates from urine or bloodstream of patients with urinary-tract-related colonization or infection at National Cheng Kung University Hospital, Taiwan were collected from July 2005 to December 2009.They were derived from 81 nondiabetic and 190 diabetic patients with available glycated hemoglobin (HbA 1C ) values within 3 months before collection of E. coli isolates. Only one isolate per patient was accepted. Diabetes mellitus was diagnosed if fasting plasma glucose concentration was ! 7.0 mmol/L (126 mg/dL) on two separate occasions, or if the patient was being treated with insulin or oral hypoglycemic agents. ABU was defined as bacterial colonization of urine in the absence of clinical symptoms. UTI was diagnosed as a quantitative culture of ! 10 5 CFU/mL for E. coli isolated from midstream urine or catheterization, and presence of symptoms or signs of lower UTI (i.e., urgency and frequency of urination, dysuria, and/or lower abdominal pain with normal body temperature) or upper UTI (i.e., body temperature ! 38. 3 C, flank pain, and/or tenderness of the costovertebral angle). Urosepsis was defined as a patient with E. coli bacteremia arising from a urinary tract source.
The E. coli strains collected from urine and bloodstream were identified using standard methods, and stored in 20% glycerol at e70
C until used in all subsequent analyses. Susceptibility of E. coli strains, using the disk diffusion method and interpretive criteria according to the Clinical and Laboratory Standards Institute guidelines of 2006, was determined to ampicillin, gentamicin, cefazolin, second-generation cephalosporins (cefuroxime, cefoxitin or cefmetazole), third-generation cephalosporins (cefotaxime, ceftriaxone, ceftazidime, cefixime or cefpodoxime), fourth-generation cephalosporins (cefepime or cefpirome), and fluoroquinolones (ciprofloxacin, levofloxacin or lomefloxacin). Intermediate susceptibility was interpreted as resistance.
Detection of E. coli K1 capsule and virulence genes K1 capsule and 14 uropathogenic virulence factor genes of E. coli were detected using polymerase chain reaction (PCR). Primer pairs specific for K1 capsule gene, neuA, were K1-F: ATGATTACTCGACACTGTC; K1-R: AACAATCTCCGCT ATTTCG. The size of the PCR products was 812 bp. Primer pairs specific for the three PapG adhesion genes (papG class IeIII) of P-fimbriae and genes for type 1 fimbrial adhesions (fimH ), S-/F1C-fimbriae (sfa/foc), afimbrial adhesions (afa), iron-regulated gene A homolog adhesion (iha), hemolysin (hlyA), cytotoxic necrotizing factor 1 (cnf1), catecholate siderophore receptor (iroN ), aerobactin receptor (iutA), outer membrane protease T (ompT ), and uropathogenic specific protein (usp) have been described previously. 6 The extraction of bacterial DNA and DNA amplification were performed. PCRs were carried out in duplicate and positive and negative control strains for the traits of interest were included in each assay. 6 
Phylogenetic analysis
The phylogenetic grouping of the E. coli isolates was determined by a PCR-based method developed by Clermont et al. 8 The presence of the chuA and yjaA genes and DNA fragment TSPE4.C2 was examined and E. coli isolates were assigned to one of the four main phylogenetic groups (A, B1, B2 or D). These results were further confirmed using a dot-blot assay. Fifty microliters of extracted E. coli DNA was pipetted onto a nitrocellulose membrane together with an equal volume of 0.2 N NaOH added to the DNA sample. The DNA was incubated at room temperature for 10 minutes, and the membrane washed with 50 mL buffer [0.5 M TriseHCl (pH 7.5), 1.5 M NaCl solution] per well, and a vacuum was applied for 30 minutes. The DNA was crosslinked using a UV cross-linker device (Amersham Biosciences, Piscataway, NJ, USA) and the membrane rinsed with 2 Â SSC buffer (30 mM sodium citrate, pH 7.0, 0.3 M NaCl). After hybridization reaction with a DNA probe at 60 C for 1 hour, the membrane was exposed overnight to film for autoradiography.
Statistical analysis
The Pearson c 2 test or Fisher's exact test (2-tailed) was used for comparison of categorical variables, whereas the Wilcoxon rank sum test or one-way analysis of variance was used for comparison of continuous variables. Multivariate logistic regression analysis was used to assess the independent factors for development of E. coli urosepsis in diabetic patients. P < 0.05 was considered statistically significant. All statistical analyses were performed using JMP software (SAS Institute, Cary, NC, USA).
Results
There were 63 ABU and 97 UTI E. coli strains derived from urine, and the number of E. coli strains from urosepsis was 111. Phylogenetic group B2 was the most common. The overall antimicrobial resistance rate was 77% for ampicillin, 33% for gentamicin, 30% for cefazolin, and 32% for fluoroquinolones (Table 1) .
The sources of E. coli isolates and age and sex of the hosts were similar between diabetic and nondiabetic groups. Phylogenetic group B2 was most common in E. coli isolates. There was no significant difference in the overall virulence factors between the diabetic and nondiabetic groups, except a greater prevalence of afa gene in the diabetic group (Table 2) .
The mean HbA 1C value was highest in diabetic patients with urosepsis. Phylogenetic group B2 was most common in E. coli strains arising from a urinary tract source derived from diabetic patients. Virulence factor genes with neuA, papG II, afa and hlyA were more common in the urosepsis isolates, whereas they were relatively low in the ABU isolates (Table 3 ). Using HbA 1C and neuA, papG II, afa and hlyA genes as confounding variables for development of E. coli urosepsis, multiple logistic regression analysis revealed Table 4 . Virulence factor genes with papG II, afa and ompT were more common in the urosepsis isolates, whereas they were relatively low in the ABU isolates. The prevalence of antimicrobial resistance of E. coli isolates to second-and third-generation cephalosporins was more common in the diabetic group compared to that in the nondiabetic group. There was a trend towards decline in antimicrobial resistance to cefazolin, secondand third-generation cephalosporins, and fluoroquinolones associated with the increased severity of E. coli-related infection. The lowest rate of antimicrobial resistance of E. coli isolates was in the urosepsis subgroup (Table 5 ). There was no significant difference in antimicrobial resistance among the three groups in the nondiabetic patients (Table 5) .
Discussion
This study addressed the bacterial characteristics and glycemic control in diabetic patients with E. coli infections arising in the urinary tract. Poorer glycemic control contributed to development of urosepsis. In diabetic patients with urosepsis, the corresponding E. coli isolates were more virulent but less resistant to antibiotics than those from diabetic patients with ABU or UTI. Bacterial characteristics including papG II and afa genes were important virulence factors for development of E. coli urosepsis in diabetic patients.
It is well known that diabetic patients are immunocompromised and have an increased risk for different infections. Glycemic control is an important outcome indicator for diabetic patients with infection. 9, 10 Investigations regarding bacterial characteristics and glycemic control in E. coli-related infections arising in the urinary tract have been scarce. HbA 1C level as indicator of glycemic control reported in many studies was measured following admission or diagnosis of infection, which is difficult to understand the glycemic control prior to the development of infection. The present study included 190 diabetic patients with available HbA 1C values within 3 months before collection of E. coli isolates, related to colonization or infection of the urinary tract. This study demonstrated that diabetic patients with urosepsis had the highest HbA 1C values compared to that in the ABU and UTI groups. Besides, HbA 1C value was an independent determinant for occurrence of urosepsis. These results emphasized an important role of glycemic control in the development of E. coli urosepsis in diabetic patients. There are few data concerning the bacterial characteristics in diabetic patients with E. coli bacteremia. Previous studies have shown that the distribution of bacterial virulence factors depends on the primary source of E. coli bacteremia, and greater prevalence of most virulence characteristics contributes to the occurrence of E. coli bacteremia. 1, 11 However, several studies have revealed no significant difference in bacterial determinants between patients with and without E. coli bacteremia.
12e14 The present study demonstrated a similar bacterial virulence profile in diabetic and nondiabetic patients. E. coli isolates from urosepsis exhibited a significantly greater prevalence of neuA, papG II, afa and hlyA genes than nonurosepsis isolates in diabetic patients. Using multivariate logic regression analysis, we demonstrated that papG II and afa genes, but not neuA and hlyA genes, were important determinants for E. coli urosepsis in diabetic patients. The present study suggests that more bacterial virulence traits may be necessary for development of E. coli urosepsis in diabetic patients, and that papG II and afa genes are the important bacterial virulence factors.
Meiland et al have reported lower antimicrobial resistance rates in E. coli isolated from urine of diabetic women than those from urine samples of the general female population. 15 Bonadio et al have found that E. coli isolates are resistant at similar rates to ampicillin, cotrimoxazole, ciprofloxacin and nitrofurantoin in both diabetic and nondiabetic patients. 16 They have concluded that diabetes mellitus per se does not seem to influence the susceptibility patterns of uropathogens to antimicrobials. 16 With very few exceptions, there have been no differences observed in the antimicrobial resistance profiles between diabetic and nondiabetic groups. 17 The present study showed a similar antimicrobial resistance profile between diabetic and nondiabetic patients, except for a higher resistance rate to the second-and third-generation cephalosporins in the diabetic group. The lowest rate of resistance to cefazolin, second-and third-generation cephalosporins, and fluoroquinolones was found in the urosepsis-related E. coli isolates derived from diabetic patients. These data do not allow us to infer causality between antimicrobial resistance and different E. coli infections. Compared to diabetic patients with asymptomatic bacteriuria or UTI without bacteremia, diabetic patients with urosepsis might have received antimicrobial agents with stronger potency, higher dose, and/or longer duration to eradicate the E. coli from the bloodstream. The probability of antimicrobial-resistant E. coli strains remaining in the urinary tract of diabetic patients with urosepsis is lower than that in diabetic patients with ABU or UTI.
The main limitation of this study was its retrospective inclusion of diabetic patients with HbA 1C examined within 3 months before collection of E. coli strains, which may have affected the distribution of bacterial sources, virulence characteristics, and antimicrobial resistance profiles of E. coli isolates. In addition, diabetes and glycemic control were the main host factors investigated for association with the bacterial characteristics and E. coli infections. The role of other important host factors, such as anatomical defects and immunodeficiency, in the development of infection could not be overlooked, although they were not included for analysis in this study because of insufficient information from chart records.
In conclusion, this study demonstrated the important roles of glycemic control and bacterial characteristics in E. coli infections arising in the urinary tract in diabetic patients. More virulence characteristics of E. coli isolates, especially those with papG II and afa genes, and poorer glycemic control were significantly associated with development of E. coli urosepsis in diabetic patients.
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